Clinical Trial
Accepted on 18 Nov 2025
A Multicenter, International, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of TRaumatic brain injury in Adults (MITRA)
in Neurotrauma